321 related articles for article (PubMed ID: 15377655)
1. The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO.
Lausen J; Cho S; Liu S; Werner MH
J Biol Chem; 2004 Nov; 279(47):49281-8. PubMed ID: 15377655
[TBL] [Abstract][Full Text] [Related]
2. Multiple regions of ETO cooperate in transcriptional repression.
Hildebrand D; Tiefenbach J; Heinzel T; Grez M; Maurer AB
J Biol Chem; 2001 Mar; 276(13):9889-95. PubMed ID: 11150306
[TBL] [Abstract][Full Text] [Related]
3. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
4. Domains involved in ETO and human N-CoR interaction and ETO transcription repression.
Wang J; Wang M; Liu JM
Leuk Res; 2004 Apr; 28(4):409-14. PubMed ID: 15109542
[TBL] [Abstract][Full Text] [Related]
5. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.
Wang J; Hoshino T; Redner RL; Kajigaya S; Liu JM
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10860-5. PubMed ID: 9724795
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression by leukaemia-associated ETO family members can be independent of oligomerization and coexpressed hSIN3B and N-CoR.
Olsson A; Olsson I; Dhanda RS
Biochim Biophys Acta; 2008 Oct; 1779(10):590-8. PubMed ID: 18586123
[TBL] [Abstract][Full Text] [Related]
7. [Determination of ETO interaction domain within nuclear receptor co-repressor].
Wang M; Hao C; Tang K; Xing H; Tian Z; Zhang Y; Wang J
Zhonghua Xue Ye Xue Za Zhi; 2002 Dec; 23(12):621-3. PubMed ID: 12667342
[TBL] [Abstract][Full Text] [Related]
8. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.
Amann JM; Nip J; Strom DK; Lutterbach B; Harada H; Lenny N; Downing JR; Meyers S; Hiebert SW
Mol Cell Biol; 2001 Oct; 21(19):6470-83. PubMed ID: 11533236
[TBL] [Abstract][Full Text] [Related]
9. Oligomerization of ETO is obligatory for corepressor interaction.
Zhang J; Hug BA; Huang EY; Chen CW; Gelmetti V; Maccarana M; Minucci S; Pelicci PG; Lazar MA
Mol Cell Biol; 2001 Jan; 21(1):156-63. PubMed ID: 11113190
[TBL] [Abstract][Full Text] [Related]
10. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein.
Lutterbach B; Sun D; Schuetz J; Hiebert SW
Mol Cell Biol; 1998 Jun; 18(6):3604-11. PubMed ID: 9584201
[TBL] [Abstract][Full Text] [Related]
11. Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins.
Barseguian K; Lutterbach B; Hiebert SW; Nickerson J; Lian JB; Stein JL; van Wijnen AJ; Stein GS
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15434-9. PubMed ID: 12427969
[TBL] [Abstract][Full Text] [Related]
12. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.
Melnick A; Carlile G; Ahmad KF; Kiang CL; Corcoran C; Bardwell V; Prive GG; Licht JD
Mol Cell Biol; 2002 Mar; 22(6):1804-18. PubMed ID: 11865059
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the repressor function of the nuclear orphan receptor retinoid receptor-related testis-associated receptor/germ cell nuclear factor.
Yan Z; Jetten AM
J Biol Chem; 2000 Nov; 275(45):35077-85. PubMed ID: 10940306
[TBL] [Abstract][Full Text] [Related]
14. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
[TBL] [Abstract][Full Text] [Related]
15. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors.
Lutterbach B; Westendorf JJ; Linggi B; Patten A; Moniwa M; Davie JR; Huynh KD; Bardwell VJ; Lavinsky RM; Rosenfeld MG; Glass C; Seto E; Hiebert SW
Mol Cell Biol; 1998 Dec; 18(12):7176-84. PubMed ID: 9819404
[TBL] [Abstract][Full Text] [Related]
16. The proto-oncoprotein SYT interacts with SYT-interacting protein/co-activator activator (SIP/CoAA), a human nuclear receptor co-activator with similarity to EWS and TLS/FUS family of proteins.
Perani M; Antonson P; Hamoudi R; Ingram CJ; Cooper CS; Garrett MD; Goodwin GH
J Biol Chem; 2005 Dec; 280(52):42863-76. PubMed ID: 16227627
[TBL] [Abstract][Full Text] [Related]
17. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.
Gelmetti V; Zhang J; Fanelli M; Minucci S; Pelicci PG; Lazar MA
Mol Cell Biol; 1998 Dec; 18(12):7185-91. PubMed ID: 9819405
[TBL] [Abstract][Full Text] [Related]
18. A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcription.
Wei Y; Liu S; Lausen J; Woodrell C; Cho S; Biris N; Kobayashi N; Wei Y; Yokoyama S; Werner MH
Nat Struct Mol Biol; 2007 Jul; 14(7):653-61. PubMed ID: 17572682
[TBL] [Abstract][Full Text] [Related]
19. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein.
Melnick AM; Westendorf JJ; Polinger A; Carlile GW; Arai S; Ball HJ; Lutterbach B; Hiebert SW; Licht JD
Mol Cell Biol; 2000 Mar; 20(6):2075-86. PubMed ID: 10688654
[TBL] [Abstract][Full Text] [Related]
20. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR).
Loinder K; Söderström M
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):191-6. PubMed ID: 15336696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]